Commentary - November 22, 2021
#WAAW: Fighting antibiotic resistance by strengthening our immune system
I began to be interested in the problem of antibiotic resistance almost 30 years ago. A couple of colleagues and I were evaluating some patent applications describing the possibilities of replacing antibiotics in animal feed with lactobacillus. At that time, similarly to today, antibiotics were routinely used to stimulate the growth of animals raised for […]
Commentary - June 1, 2019
Data Protection and Medical Progress: striking the right balance
An individual’s medical data is clearly one of the most private elements of personal data – quite clearly deserving of the highest level of data protection.
Commentary - November 29, 2018
Patient-focused treatments
Patient-focused treatments in cancer care – an opportunity for Swedish life science The increased knowledge in cancer biology and the introduction of new drugs have contributed to an improved survival and, in many cases, also to increased quality of life. However, not everyone benefits. In fact, the positive effects are only seen in a smaller […]
Commentary - October 31, 2018
How will brexit affect the pharmaceutical sector
How will Brexit affect the pharmaceutical sector? Brexit and the implications of the UK’s departure from the European Union (EU) continue to dominate the news agenda and industry discussions. Here, Thomas Beck, Senior Vice President, Quality Management at Recipharm, gives his views on the relocation of the European Medicines Agency (EMA), the need for a […]
